Wednesday, June 10, 2026

pharma Β· Melanoma Β· Tumor Β· NKTR

Nektar Therapeutics UK

Nektar Therapeutics UK clinical programs β€” 14 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

455 Mission Bay Boulevard South, San Francisco, California 94158, US HQ
1990 Founded
610 Employees
Public company Type
NKTR Β· NYSE Ticker
Company details
Status
Public
HQ
455 Mission Bay Boulevard South, San Francisco, California 94158, US
Founded
1990
Employees
610
Programs
57
Drugs
31
Patents
423
Intelligence Β· Clinical Programs

Nektar Therapeutics UK projects

14 ClinicalTrials.gov programs sponsored by Nektar Therapeutics UK.

Nektar Therapeutics UK has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 145 mg/m2 NKTR 102

    Nektar Therapeutics UK Limited

    Advanced or Metastatic Solid Tumors in Patients With Hepatic Impairment

    phase 1 small molecule completed

    1 trial
  2. Bempegaldesleukin

    Nektar Therapeutics UK Limited

    Covid-19

    phase 1 small molecule completed

    1 trial
  3. Bempegaldesleukin (NKTR-214)

    Nektar Therapeutics UK Limited

    Metastatic Melanoma

    phase 1 mab terminated

    1 trial
  4. C-TIL051

    Nektar Therapeutics UK Limited

    Metastatic Non Small Cell Lung Cancer

    phase 1 mab terminated

    1 trial
  5. Cyclophosphamide

    Nektar Therapeutics UK Limited

    Recurrent Diffuse Large B-Cell Lymphoma

    phase 1 small molecule active

    1 trial
  6. LY3471851

    Nektar Therapeutics UK Limited

    Dermatitis, Atopic

    phase 1 small molecule completed

    1 trial
  7. LY3471851

    Nektar Therapeutics UK Limited

    Healthy

    phase 1 small molecule completed

    4 trials
  8. NKTR-102

    Nektar Therapeutics UK Limited

    Advanced Cancer

    phase 1 small molecule completed

    1 trial
  9. NKTR-181

    Nektar Therapeutics UK Limited

    Moderate to Severe Chronic Pain

    phase 1 small molecule terminated

    1 trial
  10. NKTR-214

    Nektar Therapeutics UK Limited

    Advanced Cancer

    phase 1 mab completed

    1 trial
  11. NKTR-255

    Nektar Therapeutics UK Limited

    Multiple Myeloma

    phase 1 small molecule completed

    1 trial
  12. Nivolumab

    Nektar Therapeutics UK Limited

    Renal Cell Carcinoma

    phase 1 mab completed

    1 trial
  13. Placebo

    Nektar Therapeutics UK Limited

    Psoriasis

    phase 1 small molecule completed

    1 trial
  14. TAK-659

    Nektar Therapeutics UK Limited

    Lymphoma, Non-Hodgkin

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does Nektar Therapeutics UK have?

14 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.